The Congenital Heart Initiative: Results from a Patient-Centered Registry for Adults with Congenital Heart Disease

Scott Leezer,Mindi Messmer,Anushree Agarwal,Ruth Phillippi,Jamie L. Jackson, Mark Roeder, Aliza Marlin,Noah Peyser,Mark J. Pletcher,Richard Krasuski,Matthew Lewis,Leigh Reardon,Arwa Saidi, Ronald Kanter, Satinder Sandhu, Thomas Young, Roni Jacobsen, Emily Ruckdeschel,Adam Lubert, Simran Singh,Ali Zaidi, Dan H. Halpern, Anita Mathews, Rittal Mehta,Thomas Carton,Anitha S. John

crossref(2024)

Cited 0|Views10
No score
Abstract
Background In the United States, there are over 1.5 million adults living with congenital heart disease (CHD). The Congenital Heart Initiative (CHI) is a digital, online patient empowered registry that was created to advance multicenter research and improve clinical care by gathering patient-reported outcomes (PROs) in adults with CHD. Methods After a two year design process, the CHI was created and launched nationally on December 7, 2020 using a human centered design approach. Demographics and validated survey tools on quality of life, mental health, physical activity and health care utilization were collected at baseline and every 4 months. Data were collected virtually and stored on Health Insurance Portability and Accountability Act (HIPAA)–compliant cloud-based servers with restricted access. Results By December 31, 2023, the CHI had enrolled 4558 participants (56% female) with an average age of 39 years ± 14, representing all 50 states. Approximately 88% of participants have completed at least one e-Visit as of December 31, 2023. The most prevalent CHD anatomy included tetralogy of Fallot (883, 22%), transposition of great arteries (452, 11%), and coarctation of the aorta (429, 11%). Approximately 88% of participants reported at least one co-morbidity, with arrhythmia (1310, 29%) and mood disorder (1339, 29%) as the most common cardiac and non-cardiac co-morbidity, respectively. Among female participants, 45% (n=1147) reported having had a pregnancy with 38% (n=967) resulting in biological children. Participants with complex CHD were less likely to meet recommended physical activity guidelines (X2 (2, n = 917) = 15.9, p < 0.001), a factor that was more pronounced amongst female participants. Overall health-related quality of life was rated as good or better by 84% of participants with no difference by CHD complexity. Conclusion CHI is the largest ongoing registry of adults living with congenital heart disease in the US and includes patients with a wide variety of CHD subtypes. Many patients report mood disorders, but most report good or very good health-reported quality of life. The CHI is poised to facilitate multicenter research with the goal of improving clinical outcomes for all adults with CHD. ### Competing Interest Statement The authors have declared no competing interest. ### Clinical Trial N/A ### Funding Statement Funding Support: Health eHeart Alliance (PPRN-1306-04709); CHI-RON study (PCORI RD-2020C2-20347) ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The CHI was reviewed and approved by the Children's National Hospital Institutional Review Board (IRB) Pro00016403 and built through the Eureka platform, which has been reviewed and approved by the University of California-San Francisco IRB. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data is embargoed pending publication. For further inquiries, please email achdresearch{at}childrensnational.org * CHI : Congenital Heart Initiative CHD : Congenital Heart Disease HIPAA : Health Insurance Portability and Accountability Act PROs : Patient Reported Outcomes ACHA : Adult Congenital Heart Association CHI-RON : Congenital Heart Initiative: Redefining Outcomes and Navigation to adult centered care PCORnet : National Patient-Centered Clinical Research Network EMR : Electronic Medical Records HCD : Human centered design NDD : Neurodevelopmental Disability
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined